- Syndax's IPF drug missed primary endpoint in Phase 2.
- Syndax shares fell 19% to $13.34 after hours.
- Teradyne invests $300 million in FormFactor.
- FormFactor shares rose 3.6% to $134.90.
- Navitas shares rose 4% to $10.39.
- Syndax Pharmaceuticals shares fell 19% after-hours after its IPF drug missed a Phase 2 endpoint. Teradyne will invest $300 million in FormFactor for a semiconductor testing partnership; FormFactor rose 3.6%. Navitas Semiconductor launched a power-delivery board for Nvidia infrastructure; shares gained 4%.
The headline and the read are open. The reasons are one free account away, on every story.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
BORSAPLUSWhy it matters · Bull and bear case · Reaction against SPY and the sector · What to watch
Create a free account · no card